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psoriatic lesions contain elevated levels of 1 ,2-diacylglycerol, 
the physiologic activator of protein kinase C (PKC), suggest-
ing that PKC activation may be aberrant in psoriasis. We 
therefore have investigated the expression and properties of 
PKC isozymes in normal and psoriatic skin and in human 
skin cells. Chromatographic and immunoblot analyses re-
vealed the presence of the calcium-dependent PKC isozymes 
PKC-cx and -fJ, but not -y, in normal human epidermis. 
PKC-fJ was more prominent, constituting two thirds of the 
total calcium-dependent PKC activity. In psoriatic lesions, 
expression of both PKC-a and -fJ was decreased, with prefer-
ential reduction (80%) of PKC-fJ. Northern analysis and 
semi-quantitative polymerase chain reaction (PCR) indicated 
nO change in the mRNA levels of PKC-a and -fJ between 
normal and psoriatic epidermis. In normal epidermis, PKC-a 
was expressed mainly in the lower epidermis .. wherea~ PKC-
fJ was localized to the upper cell layers, with. v~ry mtense 
staining of CDla+ Langerhans cells. In psonasls, PKC-a 
staining was present in the lower epidermis, whereas PKC-fJ 
P rotein kinase C (PKC) [1] is a family of phospholipid-dependent serine/threonine protein kinases that func-tion to transduce extracellular signals across the cell sur-face (reviewed in [1,2]). These enzymes are activated by 1,2-diacylglycerol (DAG), which is formed as a conse-
quence of agonist-stimulated phospholipid hydrolysis [3,4] . 
Tumor-promoting phorbol esters such as 12-0-tetradecanoyl-13-
acetate (TPA) also activate the PKC family in a manner similar to 
DAG, and PKCs are the predominant cellular phorbol ester recep-
tors [5 - 7] . To date, nine mammalian genes encoding ten PKC 
isozymes have been identified [8,9] . Whereas virtually every cell 
expresses some form of PKC, the PKC isozyme composition differs 
among cell types. PKC isozymes can be broadly classified into two 
groupS based on their calcium dependence. PKC isozymes a, fJI, fJII, 
Manuscript received December 4, 1992; accepted for publication May 3, 
1993. 
Reprint requests to: Gary J. Fisher, Department of Dermatology , Kresge I, 
R6558, University of Michigan, Ann Arbor, MI 48109. 
Abbreviation: DAG, 1,2-diacylglycerol. 
staining was essentially absent, with the exception of some 
positive inflammatory cells . In addition to PKC-a and fJ, 
immunoblot and Northern/PCR analysis revealed expres-
sion of four calcium-independent PKC isozymes, J, E, t;, and 
'7, in both normal and psoriatic skin. There were no signifi-
cant differences in mRNA levels among any of these PKC 
isozymes, between normal and psoriatic skin. Soluble PKC-( 
protein was modestly increased (twofold) in psoriatic, com-
pared to normal, skin, whereas the levels of PKC-J, E, and 1] 
were unchanged. Analysis ofPKC isozyme expression in the 
three major cell types of human epidermis revealed that Lan-
gerhans cells and keratinocytes were the major sources of 
PKC-fJand PKC-(, respectively. These data demonstrate the 
diversity of PKC isozyme expression in human skin, and 
suggest that alterations of PKC-fJ and -t; may participate in 
the aberrant regulation of growth and differentiation ob-
served in psoriasis. Key words: protein kinase C isozyme 
activationjpsoriasis/l,2,-diacylglycerol. ] Invest Dermatol 
101:553-559,1993 
and yare calcium dependent, whereas PKC isozymes 6, E, (, 17, B, and 
A are calcium independent. Accumulating evidence indicates that 
certain PKC isozymes display distinct substrate specificities and re-
quirements for activation, suggesting that they may possess func-
tional specificity [10-13]. 
We have previously demonstrated that psoriatic lesions contain 
elevated phosphoinositide-specific phospholipase C activity and 
DAG content, compared to non-Iesional skin [14]. In addition, we 
have found that calcium-dependent PKC activity, determined by 
phosphorylation of histone ill lI ilro,. is significantly reduced in psori-
asis compared to normal skin [15]. Based on these observations, we 
have proposed that misregulation of the PKC signal transduction 
pathway may be an important participant in the pathophysiology of 
psoriasis [14,15] . In this study , we extend our observations to dem-
onstrate that reduced PKC activity in psoriatic lesions is largely due 
to reduced expression of PKC-j1II, which in normal skin is highly 
expressed in epidermal Langerhans cells, and to a lesser extent re-
duced PKC-a, which is expressed in all cel l types of the skin. In 
addition, we have characterized mRNA and protein expression of 
calcium-independent PKC isozymes 6, E, (, and 17 in normal and 
psoriatic skin. 
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MATERIALS AND METHODS 
Reagents Monoclonal antibodies to PKC-a and PKC-P (~hich detects 
both PKC-jJI and -jJII) were obtained from Selkagaku. Rabbit polyclonal 
antibodies to PKC-jJI , -jJII, -y, -0, -E, -(, and -II were prepared to synthetic 
peptides and characterized for specificity to each PKC isozyme expressed in 
the Bacu lovirus- insect cell expressIOn system [1 6]. Alkalllle phosphatase-
conjugated goat anti-rabbit IgG and alkaline phospharase-conjugated goat 
anti-mouse IgG were from Bio-Rad Laboratories. C hemiluminescent alka-
linc phosphatase substrate (ECL} was from Amersham. M-MLV H- reverse 
transcriptase and rabbit globin mRNA were from Gibco BRL. TAQ DNA 
polymerase was obtained from Perkin Elmer Cetus. The ABC vectostall1 
immunohistochemistry reagent kit was from Vector LaboratOries. 3-
Amino-9-cthyl carbazole was from Sigma C hemical Company. Anti-CDb 
antibody was from Becton-Dickenson. Magnetic beads coated with goat 
anti-mouse IgG were obtained from Dyna!. 
Tissue Procurement Keratome and punch biopsies from normal and 
psoriatic epidermis were obtained as previously described [17] . Keratome 
blade depths were set at 0.2 mm and 0.4 mm for normal and psoriatic skin, 
respectively, resulting in excision near the epidermal-dermal junction. 
Biopsies were composed of epidermis with some residual (approximately 
5%) dermis, as judged by histologic examination. Biopsies were either used 
immediately or snap frozen in liquid nitrogen and stored at -70·C until 
used. All procedures involvin g human subjects were approved by the Uni-
versiry of Michigan Institutiona l Review Board. 
Partial Purification and Assay of Soluble Calcium-Dependent 
PKC Previous studies demonstrated that 70 - 80% of calcium-dependent 
PKC activity in human epidermis was in the solubl e fraction [1 8]. Therefore 
the soluble fraction of epidermal homogenates was utilized to characterize 
calcium-dependent PKC isozymes. Frozen keratome biopsies from normal 
and psoriatic skin were ground under liquid nitrogen with mortar and pestle 
and homogenized in a glass homogenizer in ice in 20 mM Tris-HCI (pH 
7.5),5 mM ethyleneglycol-bis(p-aminoethyl ether)-N ,N ,N',N'-tetraacetic 
acid (EGTA), 5 mM ethylenediaminetctraacetic acid (EDTA) , 10 mM p-
mercaptoethanol, 0.1 % leupeptin. The homogenate was centrifu ged at 
100,000 Xg for 1 h at 4·C, and the supernatant applied to a diethylamin-
oethyl-5PW column (7 .5 X 0.75 cm), equilibrated with 20 mM Tris-HCl, 
(pH 7.5), 2 mM EGTA, 2 mM EDTA, 10 mM p-mercaptoethanol , 0.01 % 
leupeptin, connected to a Pharmacia fast protein liquid chromatography 
system. All chromatography was performed at 4·C in a cold room. The 
column was washed with 20 ml equilibration buffer and eluted with a linear 
gradient of NaCl (0 - 0.5 M). Fractions (0. 5 ml) containing PKC activity 
were pooled, diluted threefold with 5 mM KPO. (pH 7.5), 10% glycerol , 
0.01 % leupeptin , and applied to a high-performance hydroxylapitite col-
umn (10 X 0.78 cm) equilibrated with diluent. The column was eluted w ith 
a linear gradient of KPO. (5 - 300 mM), and fractions (0.5 ml) were assayed 
for PKC activity. 
Calcium-dependent PKC activity in column fractions was determined by 
measurement of PKC-c3talyzed incorporation of [32P]PO. into histone in 
the presence of calcium, phospholipid , and TPA as previously described 
[1 8,19]. 
Northern Blot Analysis Total RNA was isolated from keratome biopsies 
of normal and psoriatic epidermis by ces ium chloride gradient centrifuga tion 
as described [20] . Briefly, frozen keratome biopsies were ground under liq-
uid nitrogen with mortar and pestle , and homogenized in a polytron homo-
genizer in guanidinium hydrochloride lysis buffer (1 ml/ l00 mg wet 
weight). The resulting homogenate was centrifuged to remove insoluble 
debris and total RNA was obtained by cesium chloride gradient centrifuga-
tion. PolyA+ RNA, obta ined by passage of total RNA over oligo-dT cellu-
lose, was size fractionated by electrophoresis on 1.2% formaldehyde agarose 
gels and transferred to nylon membrane. Membranes were probed with 
[32P]- labcled cDNA probes specific for PKC-cx, -{J, -0, -E, -(, and -~ , gener-
ated by reverse transcriptase/polymerase chain reaction (see below) . cDNA 
probes were labeled by random priming. , 
Western Blot Analysis Soluble and particulate fractions from normal 
and psoriatic epidermis were prepared as described above, and equal amounts 
of protein (50 tJ.g) were resolved by sodium dodecylsul fate- polyacry lamide 
gel electrophoresis (SDS-PAGE) (8% gels) [21). Proteins were transferred to 
nitrocellulose membranes and blotted with specific antibodies to PKC-cx,-p 
(jJI and jJII) , -jJI , -jJII , -y, -0, -E, -(, and - ~, using standard procedures. 
PKC/antibody compl exes were visualized by autoradiography using a chem-
iluminescent substrate. Recombinant PKC isozymes, obtained by expression 
in the Baculovirus-insect ce ll expression system, were used as standards . 
Reverse Transcriptasc/Polymerase Chain Reaction Total RNA 
from keratome biopsies of normal and psoriatic epidermis and epidermal 
cel ls (keratinocytes, melanocytes, and Langcrhans cells) was prepared as 
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described above. RNA (1 mg) was reverse transcribed, using random hex-
imer primers (25 pmol) and 200 U M-MLV H- reverse transcriptase, at 
37"C for 30 min in 50 mM Tris (pH 8.3), 0.3 mM MgCI2' 20 mM dithio-
threitol, 500 mM dXTP, 20 units RNAse inhibitor. Following this, PKC 
isozyme-specific primers (50 pmol) , and TAQ DNA polymerase (2 U) were 
added , and polymerase chain reaction was carried out in 40 111M Tris (PH 
8.3), 1.5 mM MgCI2, 125 111M deoxyribonucleotides (final concentrations) 
for 30 cycles of 95·C for 30 seconds, 50-56·C (depending on the target 
being amplified) for 30 sec, and 72·C for 30 sec, with a 3-sec extension per 
cycle. The primers and annealing temperatures utilized were as follows: 
PKC-a, 5'GTCGGCAACAAAGTCATCAGTCCCTCTGAAGACAG_ 
GAAACAA, 5'TITTAACGACTGAAACCCTACACGTTCCTT, sO·C; 
PKC-{J(l/ IJ), 5'TTCCTTACACATGCCAAAATCGGCAATCTT, 5'C-
AACCAGCAGAAAAGAAGGCCC-TGGAACCAAGG, 50·C; PKC-,BI, 
5' AAGGGCATCA TTT ACCGTGAC, 5'TGGAGGTTGAAGCTGTT_ 
TCTC, 50 · C; PKC-jJII, 5'AAGGGCATCATTTACCGT GAC, 5'-
AATTTTGGGCTCAGTTCTCG, 50·C; PKC-y, 5'GGTTCTACTCA_ 
CCTCATACAA TTCCAGGGGGTAGTT, 5'GTGTGTCGCGGCCA_ 
CGT GCAAGTAGAGCGT CGTTCTTGT, 50·C; PKC-o, 5'GTGGA_ 
TTGCAAACAGTCT A TGCGCAG-TGAG, 5'TCT AGTCTGAGTCG_ 
GAGGAGTCTCGGA, 50·C; PKCE, 5'GACAATGAGAGCGTGTG_ 
TTCAGGGAACGC, 5'T AACGACCACGGCTCAGGGGCGTCG_ 
GACGA, 50·C; PKC-(, 5'CTAATGTTTGAGATGAGATGGCTGGG 
5'GTATCTGAC-CCTGAACGACCTCTT, 56·C; PKC-I/, 5'CCAGC~ 
TGAACCATCGCCAAATAGA 5' ACACAGAGGTCTT AACGTTGG, 
52·C. Primers were synthesized by the Universiry of Michigan DNA corc 
facility . 
Polymerase chain reaction products were ana lyzed by agarose gel electro_ 
phoresis and visualized by ethidium bromide staining. The authenticity of 
each product was confirmed by size and digestion with two restriction 
enzymes. 
Reverse transcriptase/polymerase chain reaction was also performed 
under conditions that allowed the relative levels of PKC isozyme transcripts 
in normal and psoriatic epidermis to be determined [22]. Rabbit globin 
mRNA (1.2 pg) and RNA from normal or psoriatic epidermis (1 fig) were 
combined and reverse transcribed as described above. Following this, 3 four-
fold di lutions of the reverse transcriptase reaction were made. To each dilu-
tion, specific PKC isozyme and rabbit p-globin primers were added, and the 
target sequences for both co-amplified as described above for 20 cycles. 
Polymerase chain reaction products were separated by agarose gel electro_ 
phoresis, transferred to nylon membrane, and simultaneously hybridized 
with [32P]-labeled PKC isozyme and p-globin probes (isolated polymerase 
chain reaction products). Radioactivi ty in the hybridized bands was quanti-
fied using a PhosphorImager (Molecular Dynamics). Results are analyzed as 
the ratio of counts in the PKC isozyme band to counts in the p-globin band. 
Over the concentration range of epidermal and rabbit globin mRNA uti-
li zed, the amount of polymerase chain reaction products formed after 20 
cycles was linearl y proportional to the amount of RNA added. 
Immunohistochemistry ofPKC-a and PKC-{J Punch biopsies for im-
munohistochemistry were oriented and embedded in gum tragacanth, snap 
frozen in isopent3ne chilled in liquid nitrogen, and stored at -70· C. Frozen 
cryostat sections (5 tl1n) of normal and psoriatic skin were stained with 
monoclonal antibodies to PKC-cx and PKC-P, using an av id in-biotin peroxi-
dase technique as described [17]. Peroxidase/antibody complexes were visu-
alized with 3-amino-9-ethyl carbazole as substrate, and sections were co un-
terstained with 1 % hematoxylin. Normal mouse IgG was used as an isotype 
control and showed no specific staining. 
Isolation of Langerhans Cells Keratome biopsies from normal epider-
mis were trypsinized (0. 25%) to produce a cell suspension, which was fil-
tered through nylon mesh to remove particulate debris. The cells were 
washed three times in calcium-, magnesium-free phosphate buffered saline 
containing 1 % fe tal bovine serum , and incubated on ice in RPM! 1640 
containing 10% fetal bovine serum, with mouse monoclonal antibody to 
CDla, for 30 min. Unbound anti-CD l a antibody was removed by washing 
the cel ls three times as above, and the ce lls were incubated on ice, with gentle 
agitation, with magnetic beads coated with goat anti-mouse IgG for 45 min 
[23]. Langerhans cells, rosetted with magnetic beads, were separated from 
non-C D la - bearing epidermal ce ll s by plac ing the epidermal cel l suspen-
sion next to a fixed magnet for 5 min. T he Langerhalls cells- depleted 
epidermal cel ls were removed by pipette from the magne t-bound Langer-
hans cells. Langerhans cells were separated from the epidermal cell suspen-
sion twice more with additional beads, as above, and the rosected Langerhans 
cel ls pooled. This procedure resulted in an epidermal cell suspension that 
was depleted of Langerhans cel ls by greater than 98%, and a preparation of ' 
Langerhans ce lls that was 90% pure, as assessed by CO l a staining. 
Culture of Human Keratinocytes and Melanocytes Adult human 
keratinocytcs and mclanocytes were cultured from keratome biopsies of 
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Figure 1. Immunoblot analysis ofPKC-a and PKC-P in normal and psoric 
atic human epidermis following chromatographic separation. A) PKC ac-
tivities in the soluble fraction from normal human epidermis (10 mg) were 
partially purified byc~1I'0mato graphy on a DEAE-5PW column. Fr~ctions 
containing PKC activity were pooled and applied to a hydroxylapatite col-
umn to separate calcium-dependent PKC isoenzymcs. This yielded two 
peaks of PKC activity, which were separately pooled, and analyzed by im-
munoblot with monoclonal antibodies to PKC-a (Ieji) and PKC-P (right). 
RB, partially purified PKC from rat brain used as a positive control; lalle I, 
first peak of PKC activity eluted from hydroxylapatite; lalle II, second. peak 
of PKC activity eluted from hydroxylapatite. Results are representative of 
fou r experiments. B) Equal amounts of soluble protein from normal and 
psoriatic epidermis were chromatographed on DEAE-5PW and hydroxyl-
apatite columns to separate PKC Isoenzymes as 111 A. The first and second 
peaks of PKC activity from normal (N) and psori~tic (INV) epiderm~s were 
separately pooled and analyzed by Immunoblot with monoclonal antibodies 
to PKC-a (lift, peak II) and PKC-P (righI, peak I) . Results are representative 
of four experiments. 
normal skin as previously described [24,25). Briefly, keratome biopsies were 
crypsi nized (0.25%) to produce an epidermal cell suspension a~1d primary 
cultures containing mostly keratll1ocytes, but II1cludll1g 1- 10 Vo melano-
cytes , were grown in complete MCDB 153 [24). After approximately 1 
week cultures were briefly treated with trypsin (0.025%) to preferentially 
remo~e melanocytes, and the melanocytes were seeded in fresh dishes in 
complete MCDB 153 containing 10 11M TPA .. TPA stll11ulated melanocyte 
oliferation, wlllle causll1g any reSIdual keratmocytes to term1l1ally dlffer-pr ." lf entiate and detach from the dish. Keratmocytes remallllng arter rcmova 0 
melanocytes were further trypsinized and expandcd by passage 111 complete 
MCDB 153. 
RESULTS 
Measurement of Calcium-Dependent PRC Isozymes in Nor-
mal and Psoriatic Epidermis We have previously reported that 
normal human epidermis expresses PKC activity that is calcIUm 
dependent and phosphorylates histone ill lIitro[18], suggest1l1g that 
human skin expresses one or more of the cal~1Um-depend~nt PKC 
isozymes a, /1, and )'. To further examine tillS, PKC ~CtiVlty from 
normal human epidermis was partially purified by lugh-perform-
ance DEAE chromatography (this yielded a single peak of calcmm-
dependent PKC activity, data not shown), and the calcium-
dependent PKC isozymes resolved b~ chromatography on hydrox-
ylapatite. Two dlstll1Ct peaks of calcIum-dependent PK<? aCtiVIty, 
which eluted at 100 mM and 170 mM KP04 , were obtall1ed from 
hydroxylapatite chromatogr.aphy (data not shown~. The first peak 
conta ined approximately twIce as much PKC actIvIty as the second 
peak. Based on the known elution positions of PKC-a, -/1, and -y 
[26,27]' peaks one and two would be expected to contain PKC-/1 
and -a, respectively. No peak of ac tivity corresponding to the ex-
pected elution position of PKC-)' (40 mM KP04 ) w as observed. 
The absence of a PKC-y peak was not due to faIlure to resolve 
PKC- y from PKC-/1, because we were able to resolve PKC-y and 
PKC-/1 in rat brain under similar conditions (data not shown). 
To confirm the presence ofPKC-a and PKC-/1 in human epider-
mis, immunoblot analysis of the two peaks ofPKC activity resolved 
by hydroxylapatite chromatography was pe~formed, using. specific 
monoclonal antibodies. The first peak of actIvIty reacted wIth antI-
body to PKC-/1, but not antibody to PKC-a, and the second peak 
reacted with PKC-a antibody, but not PKC-/1 antibody (Fig lA). 
N either peak ofPKC activity reacted with antibody to PKC-y (data 
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not shown). These data demonstrate that norma l human epidermis 
expresses PKC-a and PKC-/1 in an approximate ratio of 1 : 2. 
We previously reported that psoriatic skin lesions contain signifi-
cantly less calcium-dependent PKC activity than normal epidermis 
[53] . We th erefore next determined the levels ofPKC-a, -/1, and -y 
in psoriatic lesions by resolution on hydroxylapatite chromatogra-
phy and immunoblot, as described above. Similar to normal epider-
mis, two peaks ofPKC activity were obtained from psoriatic epider-
mis, with elution positions corresponding to PKC-/1 and PKC-a 
(data not shown). The identity of these two peaks of PKC activity as 
PKC-a and PKC-/1 was confirmed by immunoblot (data not 
shown) . C hromatography of equal amounts of protein from normal 
and psoriatic epidermis on hydroxylapa tite revealed that the levels 
of both PKC-a and -/1 were reduced in psoriatic epidermis, com-
pared to normal epidermis. PKC-a was reduced 20 ± 5% (n = 6), 
whereas PKC-/1 activity was preferentially decreased 80 ± 9% 
(n = 6), such that the ratio of PKC-a to PKC-/1 was reversed fro m 
that seen in normal epidermis to 2: 1. The preferential loss ofPKC-
/1 activity in psoriatic epidermis was observed in six of six psoriatic 
individuals. T aken together, the reduction in ac tivity ofPKC-a and 
-/1 resulted in a 60% reduction in total calcium-dependent PKC 
activity. This value is similar to our previously reported value for 
reduction in PKC activity in psorias is [15]. 
Fractions from h ydroxylapatite chromatography of normal and 
psoriatic epidermis containing PKC activity were pooled, concen-
trated, and an alyzed by immunoblot to determine the protein levels 
of PKC-a and PKC -/1. The relative levels of PKC-a and -/1 immu-
noreactive proteins in normal and psoriatic epidermis were found to 
be proportional to the relative levels ofPKC-a and -/1 activi ties (Fig 
lB). In psoriatic epidermis, both immunoreactive PKC-a and -/1 
were reduced, compared to normal epidermis, with preferential loss 
of PKC-/1 (the lane containing PKC-/1 from psoriatic epidermis 
contained four times more protein than the corresponding lane 
from normal epidermis) . The above data demonstrate that the pre-
viously observed decrease in calcium-dependent PKC activi ty in 
psoriatic epidermis is due to decreases in both PKC-a and -/1 activity 
and protein expression, w ith preferential loss of PKC-/1. 
Properties of Epidermal PRe-a and -/l We next examined 
the enzymatic properties of PKC-a and -/1 from normal and psori-
atic epidermis with respect to activa tion by calcium, TPA, and fatty 
acids. Both PKC-a and -/1 from normal and psoriatic epidermis 
required phosphatidylserine and calcium for activity, with maximal 
activation, in the presence of 100 J.lM phosphatidylserine, observed 
at 100 J.lM calcium (data not shown) . PKC-a and PKC-/1 from 
normal and psoriatic epidermis were also similarly stimulated by 
TPA. In the presence of phosphatidylserine (100 J.lM) and calcium 
(1 J.lM) maximal activation (tenfold) was observed at 10 nM TPA 
(data not shown). Interestin gly, both PKC-a and PKC-/1 from nor-
mal and psoriatic epidermis were significantly stimulated by unsat-
urated fa tty acids, in the absence of phosphatidylserine. Stimulation 
increased with increasing chain length and degree of unsaturation, 
with arachidonic acid being the most potent of the fatty acids tested. 
Arachidonic acid stimulated PKC-a to nearly 100% of the maximal 
value obtained in the presence of phosphatidylserine, calcium , and 
TPA (Fig 2A), whereas PKC-/1 was stimulated to nearly 60% of 
maximal (Fig 2B). The addition of calcium had a negligible effect 
on activation of PKC-a or PKC-/1 by aTachidonic acid (data not 
shown). 
Immunohistochemical Localization ofPRC-a and -/lin Nor-
mal and Psoriatic Human Epidermis We next examined by 
immunohistochemistry the cellular localization ofPKC-a and -/1 in 
normal and psoriatic skin. PKC-a inuTIul10reactivity in normal skin 
was observed throughout all the layers of living cells of the epider-
mis, with the highest intensity in the lower layers of keratinocytes 
(Fig 3A). A similar stainin g pattern, although of decreased intensity, 
was observed within the epidermis of psoriatic skin, and, in addi-
tion, PKC-a staining was observed in inflammatory cells within the 
dermis (Fig 3B). In contrast to PKC-a, PKC-/1 immunoreactivity 
was observed primarily in the upper two thirds of normal epidermis, 
with intense staining within a small number of scattered cells (Fig 
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Figure 2. Stimulation ofPKC-cx and PKC-fJ from normal human epider-
mis by free fatty acids. Phosphorylation of histone by partially purified 
PKC-q (A) and PKC-fJ (B) was determined in the presence of the indicated 
concentrations of free fatty acids. Results are plotted as percent of maximal 
activity observed in the presence of calcium, phosphatidylserine, and TPA. 
0, stearic acid;., oleaic acid; O,linoleic acid;., arachidonic acid. Results are 
means ± SO of duplicate determinations from one of three representative 
experiments. 
3C). In psoriatic skin, PKC-/3 stal11l11g was greatly diminished 
within the epidermis. Intense focal staining of cells observed in 
normal epidermis was essentially absent (Fig 3D). Prominent stain-
ing of inflammatory cells within the dermis and epidermis, which 
was absent in normal skin, was observed in psoriatic sk in. 
T he location and appearance of the intensely PKC-/3 staining 
cells observed in normal epidermis identifies them as Langerhans 
cell s. To determine whether loss of Langerhans cell PKC-/3 immu-
noreactivity in psoriasis was due to reduced nUlnbers of Langerhans 
cells, or to reduced Langerhans cell PKC-/3 expression, tissue sec-
tions of normal and psoriatic skin were stained with antibodies to 
COla, a specific marker for epidermal Langerhans cells. The mor-
phology and location within the epidermis of COla-positive Lan-
gerhans cell s were similar in normal epidermis and psoriatic lesions 
(data not shown). There was no difference in the number of CDla-
positive Langerhans cell s in tissue sections from normal epidermis 
(14.9 ± O.5/HPF, n = 7) and psoriatic lesions (-15.7 ± 1, n = 7). 
Taken together, the above data demonstrate that although CDla-
positive Langerhans cells are present in normal numbers in psoriatic 
skin, they express little, if any, immunoreactive PKC-/3. 
The intensity of Langerhans cell PKC-/3 staining suggests that 
Langerhans cells, which comprise only 1 - 2% of the total cells in 
human epidermis, may contain a disproportionately large amount of 
PKC activity. To determine the contribution of Langerhans cell 
PKC-/3 to the total calcium-dependent PKC activity in normal epi-
dermis, epidermal cell suspensions were depleted of Langerhans 
cells by immunoabsorption onto magnetic beads. In three experi-
ments, Langerhans cells depletion resulted in 12 - 25% decreases in 
the total calcium-dependent PKC activity (Table I). 
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Figure 3. Immunohistochemical loca lization of PKC-cx and PKC-/J in 
normal and psoriatic human epidermis. Frozen sections (5 j.l.m) from normal 
(A and C) and psoriatic (B and D) epidermis were stained with monoclonal 
antibodies to PKC-cx (A and B) and PKC-fJ (C and D) by immunoperoxidase. 
Sections were counter stained with hematoxalin and eosin. In C, arrows point 
to intense PKC-fJ staining in Langerhans cel ls in normal epidermis. In panel 
D, arrows point to inflammatory cells within the epidermis and dermis in 
psoriatic lesions. Scale bar, 40 j.l.m. 
mRNA Levels of Calcium-Dependent and -Independent 
PKC Isozymes in Normal and Psoriatic Epidermis The 
above data indicate that human epidermis expresses PKC-a and -/3, 
but not PKC-y, and that PKC-/3 is preferentially decreased in psori-
atic epidermis. We next examined expression of the calcium-inde-
pendent PKC isozymes in normal and psoriatic epidermis. PKC 
mRNA expression was determined by reverse transcription/polym_ 
erase chain reaction, using primers specific for eight human PKC 
isozymes. Polymerase chain reaction products of the correct sizes 
were obtained for PKC-a, as expected, and for PKC-fJi, PKC-fJiI, 
PKC-o, PKC-E, PKC-C, and PKC-1l (Fig 4). Consistent with bio-
chemical studies, no mRNA for PKC-y was detected (data nor 
shown) . PKC-fJII mRNA was detected in all samples examined, 
whereas that ofPKC-/31 was detectable in approximately one-half of 
the sampl es. The frequency of occurrence of PKC-/3l mRNA w as 
similar in normal and psoriatic epidermis (data not shown) . The 
authenticity of each polymerase chain reaction product was con-
firmed by digestion with two restriction enzymes (data not shown). 
Northern analysis of polyA+ RNA from pooled samples of normal 
and psoriatic epidermis (pooling of biopsies from three to four indi-
viduals was necessary to obtain sufficient quantities of total RNA to 
prepare polyA+ RNA) revealed transcripts for each of the PKC 
isozymes identified by polymerase chain reaction (Fig 5). The sizes 
of the transcripts were similar to those reported for PKC isozymes 
from humans and rodents [28-34]. Transcripts from PKC-o, -C, 
and -1'/ were detectable on Northern blots of total RNA from normal 
and psoriatic epidermis, whereas those for PKC-a:, -/3, and -E were 
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Table I. Effect of Langerhans Cel l Depletion on Epidermal 
PKC Activity" 
Relative % 
Total Total Specific Decrease 
Activity Protein Activity of Total 
(nmol/min) (mg) (nmol / min/mg) Activity 
Experiment 1 
0.46 0.83 0.56 } 25.2% Control 
D epleted 0.46 1.1 0.42 
Experiment 2 
0.62 0.59 1.05 } 12.3%' Control 
D epleted 0.45 0.49 0.92 
Experiment 3 
1.1 8 0.52 2.28 } 19.2% Control 
Depleted 0.78 0.42 1.85 
.. Epidermal cel l suspensions were prepared from keratome biopsies of norlllal human 
skin by trypsinization. Cells (8 - 107) were incubated with magnetic beads coated with 
anti-CD 1 a antibody or isotype IgG (control) to adsorb COl a+ r..,ngerhans cells. Beads 
were removed with a mag net. and control and Langer"ans cell -depleted cell suspen-
sions were homogenized and assayed for protein kinase C activity as described in 
Materials "lid Methods. 
not (data not shown), suggesting that these latter mRNAs were less 
abundant. In th e pooled sa mples shown, no apparent differences in 
relati ve band intensities between normal and psoriatic epidermis 
were observed for any of the PKC isozymes. 
Because it is difficult to prepare sufficient amounts of polyA+ 
RN A, needed for Northern analysis, from a single individual's skin 
biopsy, PKC isozy me mRNA levels in norma l and psoriatic indi-
viduals w ere determined by reverse transcriptasejpolymerase chain 
reaction, under quantitative conditions. This method utilizes total 
RNA and is at least 1,000 times more sensitive than Northern anal-
ysis. mRNA levels for each of the six PKC isozyme genes expressed 
in human skin were determined in biopsies from six normal and six 
psoriatic subjects. This analys is revea led no significant differences 
between normal and psoriatic epidermis, for any of the PKC iso-
zym es (data not shown) . These data indi.cate that the observed de-
crease in PKC-a and -fJ activity and protellllll psonasls (Fig 1) IS not 
associated with a corresponding decrease in their mRNA levels. 
Protein Levels of Calcium-Independent PKC Isozymes in 
NorDlal and Psoriatic Epidermis W e next determined the rel-
ative protein levels of the calcium-independent PKC isozymes in 
biopsies from normal and psoriatic epidermis. Biopsies were sepa-
rated into soluble and particular fractions and PKC isozymes mea-
sured by immunob lot. PKC-o was equally distributed between the 
soluble and membrane fractions, PKC-E was predominantly found 
in the particu late fraction, w hereas PKC-( and -17 were mostly in the 
soluble fraction (Fi g 6). The levels of PKC-o, PKC-E, and PKC-17 
we re similar in normal and psoriatic epidermis. In contrast, soluble 
PKC-( was elevated twofold in psoriatic , compared to normal, epi-
dermis (Fi g 6). 
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Figure 4. PKC isozymc mRNA expression ill normal human epidermis. 
Total RNA (l,ug) from normal human cpidermis was reverse transcribed as 
described in Materials alld Met/rods. Se'Juences ofPKC isozymes a,fl, y, J, E, 1/, 
and t;, were amplified by polymerase chain reaction, using PKC isozyme-spe-
cific primers. Reaction products were separated by agarose gel electrophore-
sis. The migration positions of DNA size standards is shown on the left. 
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Figure 5. Northern blot analys is of PKC isozymes in normal and psoriatic 
epidermis. PolyA+ RNA (10 Ilg/ Iane) was prepared from three pooled 
b,ops,es fro m normal (N) and psoriatic (P) skin , and hybridized with cDNA 
probes for PKC-a, fl, J, E, 1/, and t;,. generated by polymerase chain reaction 
(see Fig 6). The size of the major transcripts for cach PKC isozyme is show n 
on the leJi. 
PKC Isozyme Expression in Individual Cell Types in Human 
Skin The above data demonstrate that normal and psoriatic 
human epidermis express PKC isozymes a, {JI, {JII , 0, E, (, and '7. As 
epidermis is composed primarily of three different cell types, kerati-
nocytes , melanocytes, and Langerhans cel ls, we determined the 
PKC isozyme composition in each cel l type. For this purpose pri-
mary cultures of keratinocytes and melanocytes were propagated 
from bIOpSies of normal human epidermis. Because it is not possible 
to culture pure Langerhans cells, th ese cells were isolated from fres h 
epidermal cell suspensions by il11l11unoabsorption on magnetic 
beads. The presence of transcripts for each of eight PKC isozymes in 
these three cell types was determined by reverse transcriptasejpol-
ymerase chain reaction. Keratinocytes were found to express tran-
scripts for each of the six PKC isozymes present in human epider-
mis, PKC-a, -fJ, -0, -E, -(, and -II (Fig 7 A). Melanocytes and 
Langerhans cells, however, expressed distinct subsets of these en-
zymes. Melanocytes contained transcrip ts for PKC-a, PKC-fJ, 
PKC-o,and PKC-( (Fig 7B) , whereas Langerhans cells expressed 
predomlllantly PKC-{JII, PKC-o and PKC-( (Fig 7C). These data 
indicate that within human epidermis PKC-E and PKC-Il are ex-
pressed exclusively by keratinocytes, whereas the remaining four 
PKC isozymes are expressed in two or more cell types. 
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Figure 6. Immunoblot analys is of calcium-independent PKC isozymcs in 
normal and psoriatic epidermis. Normal and psoriatic epidermis were sepa-
rated into soluble (SUPE) and particulate (PELLET) frac tions and analyzed 
for PKC-J, E, r., and 'I, using specific polyclollal antibodies. Each lane con-
tained e'Jual amounts of protein (50 mg) from normal (NORM) and psori-
atic (INV) epidermis. Results shown arc from two normal and two psoriatic 
individuals. Similar results were observed in a total of six nornlal and six 
psoriatic samples. STD, recombinant PKC isozyme. The migration position 
of molecular weight standards is shown on the left. 
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Figure 7. Expression of PKC iso-
zymes in different cell types from 
normal human epidermis. Keratino-
cytes (A) and melanocytes (B) and 
LCs were cultured from normal sk in 
biopsies. Langerhans cells (C) were 
isolated from normal epidermis by 
immunoabsorption as described in 
Materials atJd Methods. Total RNA 
was prepared from each cel l type and 
expression of transcripts for PKC 
isozymes determined by reverse tran-
scriptasc/polymcrase chain reaction. 
The migration of positions of DNA 
size standards is shown. on the left. 
DISCUSSION 
Skin is well known to be a sensitive target for the actions of tumor-
promoting phorbol esters such as TPA. The biologic effects of these 
agents are primarily mediated by PKe. Topical treatment of human 
or rO'dent skin with TPA results in a robust response characterized 
by keratinocyte ac tivation (i.e., both growth and terminal differen-
tiation are accelerated) and inflammation [35,37] . Our demonstra-
tion that six of the genes that encode members of the PKC family 
are expressed within human epidermis provides insight into the 
molecular basis for the actions of TPA in skin, and provides ev i-
dence for the potential complexity of PKC-mediated signaling 
pathways in this tissue. 
The enzymatic properties of human skin PKC-a and -P were 
similar to those reported for these PKC isozymes in a variety of 
other tissues [38,39]. The observed activation of PKC-a and -P by 
unsaturated fatty acids, particularly arachidonic acid, is of interest 
because arachidonic acid levels are highly elevated in psoriatic skin 
[40] . The levels of arachidonic acid in psoriatic epidermis are ap-
proximately 50 11M, which in vitro was sufficient to activate epider-
mal PKC-a and -P to 100% and 60% of maximal, respectively. 
Recent evidence indicates that arachidonic acid preferentially acti-
vates soluble, rather than membrane-associated, PKC [41]. In psori-
atic epidermis, therefore, soluble PKC-a and -P may be activated by 
elevated arachidonic acid, whereas membrane-associated PKC-a 
and -P may be activated by elevated DAG. We have previously 
reported that DAG levels are increased threefold in psoriatic skin 
[14]. In addition, recent evidence indicates that arachidonic acid and 
DAG can synergistically activate protein kinase C-P, -E, and -y [42] . 
Because many of the biochemical and histologic features of the 
skin disease psoriasis resemble those ofTPA-treated skin, we com-
pared the expression of PKC isozymes in normal epidermis to that 
of psoriatic epidermis. We observed that the major difference was 
decreased PKC-P in psoriatic lesions. This is consistent with our 
previous finding of decreased calcium-dependent PKC activity in 
psoriatic epidermis [15]. Unexpectedly, in view of their relatively 
sma ll nl)mber, Langerhans cells were found to be a significant 
source ofPKC-P in normal epidermis. These cells, which represent 
1- 2% of the total epidermal cells, contained approximately 20% of 
the total calcium-dependent PKC activity (i.e., PKC-a + PKC-fl). 
Given that PKC-a and PKC-P are present in a ratio of approxi-
mately 1 : 2 in normal epidermis, and that Langerhans cells do not 
express PKC-a, Langerhans cells account for approximately 30% of 
the total PKC-P in normal human epidermis. This indicates that on 
a per-cell basis Langerhans cells contain 10- 20 times more PKC-P 
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than keratinocytes. This conclusion is consistent with data demon-
strating high levels of PKC-P expression in Langerhans cells in 
mouse skin [73] . 
In psoriatic skin, Langerhans cells PKC-pwas virtually absent, as 
determined by immunohistochemistry. Although this may have 
been due to altered epitope availability rather than decreased PKC-P 
protein, additional biochemical and immunologic data demon-
strated that this was not the case. Chromatographic resolution of 
calcium-dependent PKC isozymes revea led preferential loss of 
PKC-P activity in psoriatic epidermis, and this finding was consist-
ent with reduced PKC-P as determined by immunoblot analysis. 
The physiologic significance of the preferential loss ofPKC-P from 
Langerhans cells in psoriasis remains to be determined. It is espe-
cially intriguing, however, in view of accumulating evidence iden-
tifying the importance of the immune system in the pathophysiol-
ogy of psoriasis. Findings from clinical and laboratory studies 
suggest that abnormal T-cell activation serves as a key mechanism in 
this disease [44,45]. Because Langerhans cells function, similar to 
macrophages, to process and present antigens to T cells, they are 
intimately involved in the regulation ofT-cell activation. Evidence 
suggests that PKC is involved in macrophage activation (46- 48] 
and may therefore function similarly in Langerhans cells. 
Reduced PKC-P in Langerhans cells in psoriatic epidermis may I 
reflect PKC activation, with subsequent downregulation. Activa-
tion of PKC increases its susceptibility to proteolytic degradation, 
resulting in reduced PKC levels in a process termed "dowruegula_ 
tion." We [48] have previously demonstrated that calcium-depen-
dent PKC activity is downregulated in mouse and human skin fol-
lowing topical treatment with TPA. Alternatively, reduced PKC-P 
in Langerhans cells in psoriatic epidermis may reflect reduced syn-
thesis, although the finding that PKC-P mRNA levels were not 
reduced suggests that this is less likely. It is also possible that the 
reduction of PKC-P in Langerhans cel ls, rather than in addition to 
its activation, may have important consequences for Langerhans cell 
function in psoriasis. Elucidation of this issue must await further 
studies. 
Within keratinocytes, PKC-a was expressed predominantly in 
the lower epidermal layers, whereas PKC-P was present in the more 
mature cells in the upper epidermal layers. This suggests that the 
expression of these two calcium-dependent PKC isozymes may be 
regulated as a function of keratinocyte maturation, and may there-
fore act to transduce signals in a differentiation-specific manner. 
Similarly, the calcium-independent PKC isozymes may also be ex- I 
pressed at different stages of keratinocyte maturation. Our attempts 
to localize the calcium-independent PKC isozymes within the epi-
dermis by immunohistochemistry using the polyclonal antibodies 
used for immunoblot were unsuccessful due to high background. 
This is a common problem encountered when staining skin sections 
with rabbit antibodies, due to cross reactivity to skin keratins. 
In normal and psoriatic skin, PKC-Il was predominantly found in 
the soluble fraction. This is in contrast to a recent report demon-
strating nuclear localization of PKC-I] in A-431 cells [49] . This 
difference may be due to differential localization of PKC-I] in nor-
mal keratinocytes versus transformed epidermoid cells, or to differ-
ences in preparation of subcellular frac tions between this and the 
previous study. Our method of homogenization involves the grind-
ing of frozen tissue followed by thawing. In separate studies, we 
have observed that this procedure results in the disruption of nuclei. 
It is possible, therefore, that during homogenization PKC-I] may 
have been released from nuclei into the soluble fraction. 
Each of the three major cell types in human epidermis expressed 
at least one calcium-dependent and one calcium-independent PKC 
isozyme. Consistent with our results obtained by polymerase chain 
reaction, Gherzi et al [50] recently reported expression of PKC-a:, 
-0, and -I] mRNA in cultured human keratinocytes using Northern 
analysis . These investigators failed, however, to detect mRNA for 
PKC-P, - E, and -C. This may have been due to lower sensitivity, as 
oligonucleotide probes based on mouse PKC isozyme cDNA se-
quences were utilized. Co-expression of calcium-dependent and 
independent PKC isozymes occurs in many cell tyyes, and suggests 
that PKC isozymes possess functional specificity [1,8,9] . Increased 
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levels of DAG and arachidonic acid present in psoriatic lesions pro-
vide potential mechanisms.tl:rough ",:hich PKC maf be activated i" 
vivo in psoriasis. Recent clir:lcal studIes demonstrat1I1g the efficacy 
of cyclosporine A and other ImmunosuppressIve agents 111 the treat-
ment of psoriasis have provIded compellmg eVIdence 111 support of a 
prominent role of activa.ted T cel ls in the maintena~ce, and ~erhaps 
the initiation, of psonatlc leSIOns. Antlgen-presentmg cells, mclud-
ing Langerhans ce.lIs, in psoriatic lesions express cell-surface anti-
gens associated Wltl~ an activated p.henoty~e . W ~ speculate that 
PKC-fJ participates 111 the trans~uc~lOn of sIgnals 1I1volved 111 ~he 
regulation of Langerhans cell actIvatIOn, and that chro11lc activation 
leads to PKC-fJ downregulation. PKC activation may therefore be a' 
key participant in both the misregulation of epidermal cell homeo-
stasis and aberrant cellular immunity characteristic of psoriatic le-
sions. 
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